Feature | March 05, 2014

Carotid Artery MRI Helps Predict Strokes, Heart Attacks

Carotid Artery MRI Systems Clinical Study Trial Cath Lab Cardiac Diagnostics

This shows transverse gadolinium-enhanced T1-weighted MR images obtained superior to the carotid artery bifurcation in a 72-year-old man. L = ICA lumen. (a) Low-signal-intensity calcium (arrow) and lipid core (arrowheads) can be seen. (b) Note contouring of the ICA. The outer adventitial wall (red), lipid core (blue), calcification (green), and vessel lumen (purple) are visible.Credit: Radiological Society of North America

March 5, 2014 — Noninvasive imaging of carotid artery plaque with magnetic resonance imaging (MRI) can accurately predict future cardiovascular events like strokes and heart attacks in people without a history of cardiovascular disease, according to a study published online in the journal Radiology.

Researchers have long known that some arterial plaque is more dangerous because of its vulnerability to rupture. MRI can discern features of vulnerable plaque, such as a lipid core with a thin fibrous cap. This ability makes MRI a potentially valuable tool for identifying patients at risk for subsequent cardiovascular events.

To study the predictive value of MRI plaque imaging, researchers performed carotid artery ultrasound and MRI on 946 asymptomatic patients from the Multi-Ethnic Study of Atherosclerosis (MESA). 

The researchers used ultrasound to assess carotid wall thickness and MRI to define carotid plaque composition and the remodeling index, a measure of changes in vessel size. Imaging results were compared with cardiovascular events, including heart attacks, stroke and death, for an average of 5.5 years after examination. 

“We studied asymptomatic individuals with a low risk of cardiovascular events at baseline and used noninvasive imaging to predict the risk of an event downstream,” said David A. Bluemke, M.D, Ph.D., from the National Institutes of Health Clinical Center in Bethesda, Md.

Cardiovascular events occurred in 59 of the patients. Abnormal thickening of the carotid artery wall and the presence of a lipid core and calcium in the internal carotid artery on MRI were significant predictors of subsequent events. A lipid core was present in almost half of the patients who had an event, compared with only 17.8 percent of those who did not have an event.

“The primary factors that predicted future risk were measures of vessel wall thickness in combination with the presence or absence of a lipid core,” Bluemke said. “The presence of a lipid core was 50 percent more common in people who had subsequent events.”

Use of MRI improved the reclassification of baseline cardiovascular risk in the study group. When both the carotid remodeling index and lipid core were used for risk stratification, approximately 16 percent more patients with events and 7 percent without events were correctly reclassified compared with the use of traditional risk factors.

“The results bolster the use of MRI as a surrogate marker of efficacy in therapeutic studies and point to a role in determining which patients might need more aggressive treatments,” Bluemke said. “As risk factor prediction gets better, we’ll be able to screen more intelligently and use more intensive treatments in those individuals who face a higher risk of cardiovascular events.”

Bluemke said sequences for plaque composition could be readily added to existing carotid MRI angiography protocols for clinical purposes.

“Carotid MRI has significant advantages,” he said. “The results are more reproducible than those of ultrasound.”

Availability and cost effectiveness could limit the use of MRI, Bluemke said. However, ultrasound and computed tomography (CT) are viable alternatives for screening, he said, especially with improvements in CT dose reduction.

For more information: radiology.org

Related Content

Hitachi Medical Systems America, HMSA, Evolution 5, MRI software platform, Echelon Oval, RSNA 2015

Echelon Oval image courtesy of Hitachi Medical Systems America Inc.

Technology | Magnetic Resonance Imaging (MRI)| November 24, 2015
In conjunction with the upcoming Radiological Society of North America (RSNA) 2015 exhibition, Hitachi Medical Systems...
coherex Wave Crest LAA Occluder

Coherex WaveCrest Left Atrial Appendage (LAA) Occlusion System.

News | November 24, 2015
November 24, 2015 — Biosense Webster announced it has acquired Coherex Medical Inc., a privately held medical device
Feature | Cath Lab| November 24, 2015
November 24, 2015 — The U.S.
News | Heart Valve Repair| November 23, 2015
NaviGate Cardiac Structures Inc. (NCSI) announced that a first-in-human implant of its catheter-guided, mitral-valved...
Technology | Cardiac Diagnostics| November 20, 2015
Boston Heart Diagnostics announced the launch of StatinSmart, an at-home saliva laboratory developed test that analyzes...
Boston Scientific, Watchman FLX, LAA closure device, CE mark, first European implants

Image courtesy of Boston Scientific

News | Left Atrial Appendage (LAA) Occluders| November 20, 2015
Boston Scientific announced the first implants of the Watchman FLX left atrial appendage closure (LAAC) device
Rijuven, CardioSleeve for Pediatrics, FDA clearance, stethoscopes

Image courtesy of Rijuven

Technology | Stethoscopes| November 19, 2015
Rijuven announced the launch of CardioSleeve for Pediatrics, the first U.S. Food and Drug Administration (FDA)-cleared...
News | Blood Testing| November 18, 2015
Konica Minolta Inc. announced that it has developed the SPFS Immunoassay System, capable of highly sensitive...
Fraunhofer MEVIS, MRI, CaFuR, real-time MRI, beating heart

The software developed by Fraunhofer MEVIS automatically identifies the breathing and heart contraction phases in the data independent of the ECG information. This allows for a fast and easy examination of heart patients. Image courtesy of Fraunhofer MEVIS.

News | Magnetic Resonance Imaging (MRI)| November 18, 2015
Today, magnetic resonance imaging (MRI) allows more gentle, precise and cost-effective heart disease diagnosis. However...
Overlay Init